News

Filter

Current filters:

VyvanseFinancial

Shire posts top year-end results and expects earnings to rise again in 2014

Shire posts top year-end results and expects earnings to rise again in 2014

13-02-2014

Ireland-headquartered drugmaker Shire has recorded a rise in sales and earnings to deliver strong full-year…

DermagraftFinancialFirazyrIntunivLialdaMezavantNorthern EuropePharmaceuticalShireViroPharmaVprivVyvanse

US FDA adds new indication for Shire's ADHD drug Vyvanse; 1st-qtr results

02-05-2013

Ireland-headquartered Shire (LSE: SHP) says that the US Food and Drug Administration has approved its…

FinancialNeurologicalNorth AmericaPharmaceuticalRegulationShireVyvanse

Shire agrees to settlement with US government over ADHD drug marketing

04-02-2013

Ireland-headquartered drugmaker Shire (LSE: SHP) said on Friday that it has reached an agreement in principle…

Adderall XRDaytranaFinancialLegalNeurologicalNorth AmericaPharmaceuticalShireVyvanse

Shire forecasts strong 2012 EPS growth on record 2011 sales; Vyvanse news

10-02-2012

Shire (LSE: SHP), the UK’s third-largest drugmaker, posted a pleasing set of financial for full-year…

FinancialNeurologicalNorth AmericaPharmaceuticalRegulationShireVyvanse

COMPANY SPOTLIGHT

Menarini

Back to top